7-137885100-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_194071.4(CREB3L2):c.1165G>A(p.Val389Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,614,110 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_194071.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CREB3L2 | NM_194071.4 | c.1165G>A | p.Val389Ile | missense_variant | 10/12 | ENST00000330387.11 | |
CREB3L2 | NM_001318246.2 | c.976G>A | p.Val326Ile | missense_variant | 10/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CREB3L2 | ENST00000330387.11 | c.1165G>A | p.Val389Ile | missense_variant | 10/12 | 1 | NM_194071.4 | P1 | |
CREB3L2 | ENST00000456390.5 | c.1165G>A | p.Val389Ile | missense_variant | 10/10 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.0000789 AC: 12AN: 152152Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251292Hom.: 1 AF XY: 0.0000442 AC XY: 6AN XY: 135818
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461840Hom.: 1 Cov.: 31 AF XY: 0.0000303 AC XY: 22AN XY: 727220
GnomAD4 genome ? AF: 0.0000788 AC: 12AN: 152270Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74448
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 17, 2022 | The c.1165G>A (p.V389I) alteration is located in exon 10 (coding exon 10) of the CREB3L2 gene. This alteration results from a G to A substitution at nucleotide position 1165, causing the valine (V) at amino acid position 389 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at